Financial reports
10-K
2023 FY
Annual report
12 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
19 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
10-K/A
2022 FY
Annual report (amended)
19 Apr 23
10-K
2022 FY
Annual report
14 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
Current reports
8-K
Entry into a Material Definitive Agreement
2 Feb 24
8-K
Entry into a Material Definitive Agreement
30 Oct 23
8-K
Regulation FD Disclosure
23 Aug 23
8-K
Entry into a Material Definitive Agreement
13 Jul 23
8-K
Amendments to Articles of Incorporation or Bylaws
19 May 23
8-K
High Intra-Tumor TGF-β2 Predicts Poor Survival in Pediatric Cancer of the Brainstem
13 Mar 23
8-K
Departure of Directors or Certain Officers
2 Mar 23
8-K
Oncotelic Issues Year End Message to Shareholders
3 Jan 23
8-K
Regulation FD Disclosure
20 Dec 22
8-K
Regulation FD Disclosure
15 Jul 22
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
18 Apr 24
POS AM
Prospectus update (post-effective amendment)
12 Apr 24
D
$5.00 mm in debt / options / securities to be acquired, 15 investors
13 Jul 23
424B3
Prospectus supplement
2 May 23
POS AM
Prospectus update (post-effective amendment)
19 Apr 23
POS AM
Prospectus update (post-effective amendment)
14 Apr 23
424B3
Prospectus supplement
11 May 22
POS AM
Prospectus update (post-effective amendment)
26 Apr 22
424B3
Prospectus supplement
27 Sep 21
S-3/A
Shelf registration (amended)
7 Sep 21
Proxies
DEF 14A
Definitive proxy
25 Jun 20
PRER14A
Preliminary revised proxy
20 May 20
PRER14A
Preliminary revised proxy
17 Apr 20
PRE 14A
Preliminary proxy
13 Apr 20
PRER14A
Preliminary revised proxy
18 Nov 19
PRE 14A
Preliminary proxy
18 Oct 19
PRER14C
Preliminary revised information
13 Jun 19
PRE 14C
Preliminary information
22 May 19
DEFA14A
Additional proxy soliciting materials
7 May 18
DEF 14A
Definitive proxy
7 May 18
Other
EFFECT
Notice of effectiveness
26 Apr 23
EFFECT
Notice of effectiveness
6 May 22
EFFECT
Notice of effectiveness
10 Sep 21
EFFECT
Notice of effectiveness
3 Jun 21
CORRESP
Correspondence with SEC
28 May 21
UPLOAD
Letter from SEC
27 May 21
UPLOAD
Letter from SEC
26 Jun 20
CORRESP
Correspondence with SEC
19 May 20
UPLOAD
Letter from SEC
4 May 20
CORRESP
Correspondence with SEC
13 Apr 20